Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6SM1

Wild type immunoglobulin light chain (WT-1)

Summary for 6SM1
Entry DOI10.2210/pdb6sm1/pdb
Related4nki
DescriptorImmunoglobulin lambda variable 2-14, CALCIUM ION, DI(HYDROXYETHYL)ETHER, ... (5 entities in total)
Functional Keywordsal amyloidosis, antibody folding, protein stability, dynamics, immune system
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight12371.54
Authors
Kazman, P.,Vielberg, M.-T.,Cendales, M.D.P.,Hunziger, L.,Weber, B.,Hegenbart, U.,Zacharias, M.,Koehler, R.,Schoenland, S.,Groll, M.,Buchner, J. (deposition date: 2019-08-21, release date: 2020-03-18, Last modification date: 2024-01-24)
Primary citationKazman, P.,Vielberg, M.T.,Pulido Cendales, M.D.,Hunziger, L.,Weber, B.,Hegenbart, U.,Zacharias, M.,Kohler, R.,Schonland, S.,Groll, M.,Buchner, J.
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
Elife, 9:-, 2020
Cited by
PubMed Abstract: In systemic light chain amyloidosis, an overexpressed antibody light chain (LC) forms fibrils which deposit in organs and cause their failure. While it is well-established that mutations in the LC's V domain are important prerequisites, the mechanisms which render a patient LC amyloidogenic are ill-defined. In this study, we performed an in-depth analysis of the factors and mutations responsible for the pathogenic transformation of a patient-derived λ LC, by recombinantly expressing variants in . We show that proteolytic cleavage of the patient LC resulting in an isolated V domain is essential for fibril formation. Out of 11 mutations in the patient V, only one, a leucine to valine mutation, is responsible for fibril formation. It disrupts a hydrophobic network rendering the C-terminal segment of V more dynamic and decreasing domain stability. Thus, the combination of proteolytic cleavage and the destabilizing mutation trigger conformational changes that turn the LC pathogenic.
PubMed: 32151314
DOI: 10.7554/eLife.52300
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.55 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon